Imidazole derivatives, pharmaceutical compositions containing them and their preparation
申请人:SYNTEX (U.S.A.) INC.
公开号:EP0013786B1
公开(公告)日:1982-10-06
WALKER K. A. M.; WALLACH M. B.; HIRSCHFELD D. R., J. MED. CHEM., 1981, 24, NO 1, 67-74
作者:WALKER K. A. M.、 WALLACH M. B.、 HIRSCHFELD D. R.
DOI:——
日期:——
US4172141A
申请人:——
公开号:US4172141A
公开(公告)日:1979-10-23
1-(Naphthylalkyl)-1H-imidazole derivatives, a new class of anticonvulsant agents
作者:Keith A. M. Walker、Marshall B. Wallach、Donald R. Hirschfeld
DOI:10.1021/jm00133a015
日期:1981.1
anticonvulsant activity has been demonstrated for a large number of 1-(naphthylalkyl)-1H-imidazoles containing a variety of functional groups in the alkylene bridge. The presence of a small oxygen function in the bridge, in general, confers a high therapeutic index between anticonvulsant and depressant activity. Clinical expectations are discussed for 1-(2-naphthoylmethyl)imidazole hydrochloride (5), which is
Compounds of the formula ##STR1## wherein R is alkyl, benzyl, substituted benzyl, phenyl or substituted phenyl, said substituted benzyl and substituted phenyl substituted on the phenyl ring with from one to three substituents independently selected from the group consisting of halo, lower alkyl and trifluoromethyl; X is oxygen or sulfur; and the pharmaceutically acceptable acid addition salts thereof are CNS-active agents, inhibitors of gastric secretion and antifungal, antibacterial and antiprotozoal agents.